Gene · 10747
Papers2,026
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,026
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| De Novo Design and Synthesis of Polypeptide Immunomodulators for Resetting Macrophage Polarization. | Biodes Res | 2023 | 37849457 | PubTator, text mining | PubMed |
| Mannose-Binding Lectin 2 as a Potential Therapeutic Target for Hepatocellular Carcinoma: Multi-Omics Analysis and Experimental Validation. | Cancers (Basel) | 2023 | 37835594 | PubTator, text mining | PubMed |
| Emerging roles of the CIP2A-TopBP1 complex in genome integrity. | NAR Cancer | 2023 | 37829116 | PubTator, text mining | PubMed |
| Plasma proteomic associations with genetics and health in the UK Biobank. | Nature | 2023 | 37794186 | PubTator, text mining | PubMed |
| Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease. | Front Immunol | 2023 | 37781380 | PubTator, text mining | PubMed |
| Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels. | Front Immunol | 2023 | 37771595 | PubTator, text mining | PubMed |
| Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2023 | 37771589 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis of Exosomes Derived from Patients Infected with Non-Tuberculous Mycobacterium and Mycobacterium tuberculosis. | Microorganisms | 2023 | 37764178 | PubTator, text mining | PubMed |
| Host-Derived Extracellular Vesicles in Blood and Tissue Human Protozoan Infections. | Microorganisms | 2023 | 37764162 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of the Response of the Toxic Dinoflagellate Prorocentrum lima to Phosphorous Limitation. | Microorganisms | 2023 | 37764060 | PubTator, text mining | PubMed |
| TDP-43 Epigenetic Facets and Their Neurodegenerative Implications. | Int J Mol Sci | 2023 | 37762112 | PubTator, text mining | PubMed |
| DNA Polymorphisms and mRNA Levels of Immune Biomarkers as Candidates for Inflammatory Postpartum Disorders Susceptibility in Italian Buffaloes. | Vet Sci | 2023 | 37756095 | PubTator, text mining | PubMed |
| A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP). | Clin Rheumatol | 2023 | 37755547 | PubTator, text mining | PubMed |
| Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy. | Drugs | 2023 | 37747686 | PubTator, text mining | PubMed |
| Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection. | PeerJ | 2023 | 37744234 | PubTator, text mining | PubMed |
| Role of telitacicept in the treatment of IgA nephropathy. | Eur J Med Res | 2023 | 37737205 | PubTator, text mining | PubMed |
| Complement Proteins L-Ficolin and M-Ficolin Are Increased in Patients With Axial Spondyloarthritis and Decrease After Tumor Necrosis Factor Inhibitor Treatment. | J Rheumatol | 2023 | 37714550 | PubTator, text mining | PubMed |
Differential modulation of IL-4, IL-10, IL-17, and IFN-γ production mediated by IgG from Human T-lymphotropic virus-1 (HTLV-1) infected patients on healthy peripheral T (CD4+, CD8+, and γδ) and B cells. | Front Med (Lausanne) | 2023 | 37711742 | PubTator, text mining | PubMed |
| Challenges in IgA Nephropathy Management: An Era of Complement Inhibition. | Kidney Int Rep | 2023 | 37705895 | PubTator, text mining | PubMed |
| Endothelial Glycocalyx Injury in SARS-CoV-2 Infection: Molecular Mechanisms and Potential Targeted Therapy. | Mediators Inflamm | 2023 | 37674786 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10747/papers?page=8